Candriam SCA’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-4,167
Closed -$330K 836
2018
Q2
$330K Hold
4,167
0.01% 728
2018
Q1
$359K Hold
4,167
0.01% 711
2017
Q4
$520K Sell
4,167
-833
-17% -$104K 0.01% 670
2017
Q3
$750K Buy
+5,000
New +$750K 0.01% 611
2015
Q2
Sell
-317
Closed -$644K 657
2015
Q1
$644K Sell
317
-1,350
-81% -$2.74M 0.01% 510
2014
Q4
$3.21M Buy
+1,667
New +$3.21M 0.07% 298